Abstract
Yeast has been engineered to convert simple sugars and amino acids into drugs that inhibit a neurotransmitter molecule. The work marks a step towards making the production of these drugs more reliable and sustainable.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 504-505 |
| Number of pages | 2 |
| Journal | Nature |
| Volume | 585 |
| Issue number | 7826 |
| DOIs |
|
| State | Published - Sep 24 2020 |
All Science Journal Classification (ASJC) codes
- General
Keywords
- Biotechnology
- Microbiology
- Synthetic biology